Agonistic autoantibodies targeting AT1R and ETAR: Mechanistic insights and emerging implications in cardiovascular disease. [PDF]
Tona F, Bernava G, Civieri G.
europepmc +1 more source
Angiotensin-converting enzyme inhibitors vs. receptor blockers in heart failure with mildly reduced ejection fraction. [PDF]
Weidner K +10 more
europepmc +1 more source
S100A4-lineage cells contribute modestly to angiotensin II-mediated thoracic aortic aneurysms through angiotensin II type 1a receptor in mice. [PDF]
Ito S +6 more
europepmc +1 more source
Mineralocorticoid Receptor Antagonists in Chronic Kidney Disease: Clinical Evidence, Pharmacology, and Drug-Drug Interactions for Personalized Management of Hyperkalemia. [PDF]
Hirai T, Katayama K.
europepmc +1 more source
New Horizons in IgA Nephropathy: Approach to Current and Emerging Therapies. [PDF]
Madhavaram SK +3 more
europepmc +1 more source
Decoding the Heart Failure Peptidome. [PDF]
Madsen CT +10 more
europepmc +1 more source
Real-world evidence with dapagliflozin in heart failure with reduced ejection fraction in Central Eastern Europe and the Baltic region (EVOLUTION-HF CEE-BA Study). [PDF]
Leszek P +9 more
europepmc +1 more source
Endogenous and exogenous determinants of sex differences in blood pressure. [PDF]
Shangguan S +4 more
europepmc +1 more source
The Association Between Glucagon-like Peptide-1 Receptor Agonists and Clinical Outcomes in Patients with Thoracic Aortic Aneurysm. [PDF]
Raslan MA +7 more
europepmc +1 more source

